잠시만 기다려 주세요. 로딩중입니다.

Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 2 of 2

대한비뇨기종양학회지 2021년 19권 1호 p.1 ~ 15
Ghose Amit, Khochikar Makarand, Sabnis Ravindra, Parmar Naveen Magendra, Purkait Indranil,
소속 상세정보
 ( Ghose Amit ) - Apollo Gleneagles Hospitals Limited
 ( Khochikar Makarand ) - Siddhi Vinayak Ganapati Cancer Hospital Department of Uro-Oncology
 ( Sabnis Ravindra ) - Muljibhai Patel Urological Hospital Department of Urology
 ( Parmar Naveen Magendra ) - Ipca Laboratories Ltd. Medical Affairs and Clinical Research
 ( Purkait Indranil ) - Ipca Laboratories Ltd. Medical Affairs and Clinical Research

Abstract


With limited/no guidelines on prostate cancer (PCa) diagnosis and management currently in India, this consensus statement has been developed to evaluate Indian literature and current clinical practices to assist healthcare professionals across India in the diagnosis and management of patients with PCa. A group of leading PCa experts from across India convened at the 2019 CAP summit in Kolkata, India, to vote on 42 consensus statements on PCa diagnosis and management. In the subsequent meeting, an expert panel discussed on the consensus results. On the basis of the voting results and the subsequent expert panel discussion, 5 of 42 statements were deleted and 37 were accepted and retained in the final draft, which is divided into 2 parts. This paper covers part 2, which describes in detail the remaining 21 of 37 statements on locally advanced PCa and metastatic PCa with varying degrees of support from the panel. The consensus statement extrapolated from Indian scientific evidences, regional clinical experiences, and international guidelines will serve as a reference guide for clinicians across India in the diagnosis and management of PCa.

키워드

Prostate cancer; Guideline; Prostate-specific antigen; Prostatectomy; Consensus

원문 및 링크아웃 정보

등재저널 정보